Efficacy of histaminergic drugs in experimental motion sickness
The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Abstract
The purpose of this investigation was to evaluate the efficacy of the histaminergic drug "Betahistine dihydrochloride" in experimental motion sickness in 10 healthy volunteers (mean age 19.4 y.o.) with high susceptibility to motion sickness. Motion sickness was modeled using Coriolis (precession) accelerations (cumulative Coriolis stimulation test--CCST). Each subject took 32 mg of "Betahistine dihydrochloride" or placebo under "double-blind" conditions 1 hour before testing. The duration and slow phase velocity of the post-rotational nystagmus, the pursuit eye tracking test, and the latency, velocity and accuracy of saccades were estimated. The tolerability level of the CCST in volunteers in the betahistine series was shown to be significantly (p<0.001) higher, as compared to placebo and baseline. The mean illusory sensations score for the experimental series was significantly lower than that in the placebo and baseline series (p < 0.01). It was found that "Betahistine" demonstrated antimotion sickness efficacy and improved oculomotor activity (increased gain during pursuit movements, faster and more accurate saccades).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Betahistine, an H 3 receptor antagonist and a weak H 1 receptor agonist, is effective in the preventing seasickness and increases tolerability to Coriolis accelerations via reducing histamine release in medial VN [88,89].”
From Motion Sickness: Current Knowledge and Recent Advance. (2016) · cites this paper as [89]
In the citing paper
“| Betahistine | p.o. (32 or 48 mg) | 1-2 h before MS | Seasickness and experimental MS | [89] [177] |”
From Motion Sickness: Current Knowledge and Recent Advance. (2016) · cites this paper as [89]
Citations
Cites
(1968) · PubMed · Cited by 428
Histaminergic Mechanisms in Brain
Schwartz, J. (1977) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.17.040177.001545 · Cited by 257
Bouthenet, M. L., Ruat, M., Sales, N., Garbarg, M., & Schwartz, J. C. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90167-4 · Cited by 178
Enhancement by histamine of NMDA-mediated synaptic transmission in the hippocampus
Bekkers, J. (1993) · Science · doi:10.1126/science.8391168 · Cited by 171
Identification of two H3-histamine receptor subtypes.
West, R. E., Zweig, A., Shih, N., Siegel, M. I., Egan, R. W., & Clark, M. A. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09479-9 · Cited by 162
Histamine and Betahistine in the Treatment of Vertigo: Elucidation of Mechanisms of Action
Lacour, M., & Sterkers, O. (2001) · CNS Drugs · doi:10.2165/00023210-200115110-00004 · Cited by 152
Antivertigo Medications and Drug-Induced Vertigo
Rascol, O., Hain, T. C., Brefel‐Courbon, C., Benazet, M., Clanet, M., & Montastruc, J. (1995) · Drugs · doi:10.2165/00003495-199550050-00002 · Cited by 104
Wang, J.-J., & Dutia, M. B. (1995) · Experimental Brain Research · doi:10.1007/bf00242178 · Cited by 93
Betahistine Dihydrochloride Treatment Facilitates Vestibular Compensation in the Cat
Tighilet, B., Léonard, J., & Lacour, M. (1995) · Journal of Vestibular Research · doi:10.3233/ves-1995-5106 · Cited by 90
Betahistine: A Retrospective Synopsis of Safety Data
Jeck-Thole, S., & Wagner, W. (2006) · Drug Safety · doi:10.2165/00002018-200629110-00004 · Cited by 88
Cited by
Motion Sickness: Current Knowledge and Recent Advance.
Zhang, L., Wang, J., Qi, R., Pan, L., Li, M., & Cai, Y. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12468 · Cited by 216
Rahimzadeh, G., Tay, A., Travica, N., Lacy, K. E., Mohamed, S. M. K., Nahavandi, D., Pławiak, P., Qazani, M. R. C., & Asadi, H. (2023) · Nutrients · doi:10.3390/nu15061320 · Cited by 42
Peng, S., Zhuang, Q., He, Y.-C., Zhu, J., & Wang, J. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.02.040 · Cited by 28
Antihistamines for motion sickness
Karrim, N., Byrne, R., Magula, N. P., & Saman, Y. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012715.pub2 · Cited by 26
Zhuang, Q., Wu, Y., Wu, G., Zhu, J., & Wang, J. (2012) · Neurosignals · doi:10.1159/000341980 · Cited by 22
Metadata
- Authors
- Matsnev, E. I., & Sigaleva, E. E.
- Affiliations
- Department of Physiology and Pathology of Auditory and Vestibular Systems, Federal Scientific Center (FSC), Institute for Biomedical Problems, Russian Academy of Sciences (RAS), Moscow, Russia
- Russian Academy of Sciences (RU)
- Corresponding author
- Sigaleva, E.E.
- ORCID
- Sigaleva, E.E.
- Venue
- Journal of Vestibular Research
- Publisher
- SAGE Publications
- Published
- 2008-07-03
- Volume
- 17
- Issue
- 5-6
- Pages
- 313-321
- ISSN
- 0957-4271 (ISSN-L)
- 1878-6464
- OpenAlex
- W1674739742
- Cited by
- 10
- References
- 30
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 1 · 2017: 1 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Vestibular Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Vestibular and auditory disorders
- Health Sciences › Medicine › Surgery › Nausea and vomiting management
- Health Sciences › Medicine › Physiology (medical) › Spaceflight effects on biology
- Keywords
- motion sickness, betahistine, pursuit eye movements, saccades, oculomotor function, placebo comparison
- MeSH terms
- Adolescent, Adult, Betahistine, Coriolis Force, Humans, Male, Motion Sickness, Nystagmus, Pathologic, Rotation, Vestibular Diseases, Histamine Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of histaminergic drugs in experimental motion sickness. https://app.cochat.ai/papers/10.3233/ves-2007-175-611
- The paper
- Matsnev, E. I., & Sigaleva, E. E. (2008). Efficacy of histaminergic drugs in experimental motion sickness. Journal of Vestibular Research. https://doi.org/10.3233/ves-2007-175-611
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.